Success Metrics

Active Trials
2(67%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
1
33%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Other(1)

Detailed Status

Active, not recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)

Trials by Status

active_not_recruiting267%
unknown133%

Recent Activity

2 active trials
Showing 3 of 3
active_not_recruitingphase_2

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

NCT05120284
active_not_recruitingphase_3

Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

NCT02616484
unknownnot_applicable

Isoniazid Dosage Prediction Model Development

NCT02747654

Clinical Trials (3)

Showing 3 of 3 trials
NCT05120284Phase 2

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

Active Not Recruiting
NCT02616484Phase 3

Trial of Dichloroacetate in Pyruvate Dehydrogenase Complex Deficiency:

Active Not Recruiting
NCT02747654Not Applicable

Isoniazid Dosage Prediction Model Development

Unknown

All 3 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
3